Najat Khan, CEO and President: Recursion Pharmaceuticals RXRX Planned sale · Filed 25/12/22

Trade details

Type: Planned sale notice
Stock: Recursion Pharmaceuticals RXRX
Person: Najat KhanCEO and President
Planned sale date: 25/12/22
Filed: 25/12/22

$548.6K to be sold

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/22~01/21

Najat Khan's recent trades

Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$78.8K
22,408 sh
$78.8K
Filed 09/08
Traded 09/08
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.4K
23,588 sh
$84.4K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.5K
23,588 sh
$84.5K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.8K
28,298 sh
$94.8K
Filed 03/11
Traded 03/09
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.7K
28,298 sh
$94.7K
Filed 03/09
Traded 03/09

Najat Khan, CEO — plans to sell 124,403 sh of Recursion Pharmaceuticals RXRX · $548.6K · around 12/22 · 10b5-1 plan | Whalegun